Co-Diagnostics Financial Overview
Co-Diagnostics's market cap is currently $14.99M. The company's EPS TTM is $-0.16; its P/E ratio is -0.27; Co-Diagnostics is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $-0.12. See an overview of income statement, balance sheet, and cash flow financials.
